In HNSCC, TRM cells are linked to better prognosis in primary tumors but not in metastatic tumors. Both primary and recurrent tumors contain TRM cells with high TIM3 expression, unlike lymph node metastases. This evidence concerns the gene HAVCR2 and metastatic neoplasm.